Scivita Medical Technology Valuation, Funding & Investors

Scivita Medical Technology is valued at $1.1B as of August 2021.

Last Scivita Medical Technology valuation

$1.1B

Series B · Aug 2021

Last Scivita Medical Technology funding round

$62M

Series B · Aug 2021

Cumulative funding Scivita Medical Technology raised

$123M

across 2 funding rounds

Key investors in Scivita Medical Technology

  • Matrix Partners China
  • Lilly Asia Ventures
  • GL Ventures LLC
  • Medtronic
  • Chengwei Capital
  • Inno-Chip

Scivita Medical Technology Overview

About Scivita Medical Technology

Scivita Medical Technology is a medical device manufacturer specializing in advanced endoscopy systems for minimally invasive diagnostics and surgery. Its portfolio includes 4K ultra-high-definition endoscopes, 3D visualization platforms, narrow-band imaging for fluorescence, and single-use disposable scopes covering flexible and rigid formats. Headquartered in Hangzhou, China, the firm holds certifications from China's NMPA and exports to over 50 countries. Scivita supplies products to hospitals in gastroenterology, urology, and ENT fields, with notable deployments in Asia-Pacific surgical centers.


Founded

2016

HQ

ChinaSuzhou

Status

Privately held

Customer focus

B2B

Revenue model

Product sales

Valuation

$1.1B (Aug 2021)

Scivita Medical Technology Valuation

Scivita Medical Technology is currently valued at $1.1B, based on its Series B in August 2021.

The $62M round included Matrix Partners China, Prime Capital, GL Ventures LLC, Hudson Bay Capital Management and Lilly Asia Ventures.

Scivita Medical Technology valuation by funding round

Scivita Medical Technology valuation by funding round
DateStageValuation
Aug 2021Series B$1.1B

Scivita Medical Technology Funding History

Scivita Medical Technology has raised a total of $123M across 2 funding rounds.

Scivita Medical Technology's first fundraising round was a $61M Series A in April 2021. The most recent completed round was a $62M Series B in August 2021.

Scivita Medical Technology funding rounds

Scivita Medical Technology funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Aug 2021Series BMatrix Partners China; Prime Capital; GL Ventures LLC; Hudson Bay Capital Management; Lilly Asia Ventures$62M$1.1BScivita Medical Technology Co., Ltd., founded in 2016, is a high-tech medical device company specializing in minimally invasive vision solutions, particularly in endoscopes and related technologies such as ultra-high-definition 4K UHD visualization, 3D imaging, fluorescence imaging, and single-use endoscopic consumables. Headquartered in Suzhou Industrial Park, China, with an R&D center in Tokyo, Japan, the company focuses on optical diagnosis, multidimensional imaging, high-performance materials, and precision manufacturing for both flexible and rigid endoscopy applications. The Series B funding round occurred on August 5, 2021, raising $61.91 million from investors including GL Ventures, Hudson Bay Capital Management, Lilly Asia Ventures, Matrix Partners China (MPC), and Prime Capital. This followed a Series A round on April 26, 2021, securing nearly 400 million yuan (approximately $61 million USD) led by GL Ventures and Lilly Asia Ventures, with participation from Matrix Partners China, Medtronic, Chengwei Capital, and Shanghai Innochip Investment. Scivita Medical has achieved key regulatory milestones around this period, including FDA clearance for its 4K UHD Laparoscope in February 2021, NMPA and CE approvals for products like 3D visualization systems, single-use hysteroscopes, choledochoscopes, and urology videoscopes, and PMDA approval for single-use urology videoscopes. The company entered a strategic partnership with Medtronic and acquired Japanese firm ARS, positioning it as a leader in China for 3D and 4K UHD endoscopy with global penetration in America, Europe, and Asia. Scivita was recognized as a potential unicorn by Greatwall Strategy Consultants in 2021 and received awards like the China Medical Equipment Excellence List in 2022, reflecting strong market validation in high-performance endoscopic technologies amid growing demand for disposable endoscopes and emerging endoscopy innovations.
Apr 2021Series AGL Ventures LLC (lead); Lilly Asia Ventures (lead); Matrix Partners China; Medtronic; Chengwei Capital; Inno-Chip$61M-Scivita Medical Technology raised funding across multiple rounds in 2021 to support its global expansion strategy. The company completed a Series B financing round on August 5, 2021, raising $61.91M USD with investors including GL Ventures, Hudson Bay Capital Management, Lilly Asia Ventures, MPC, and Prime Capital. An earlier Series A round occurred on April 26, 2021. The company also announced receipt of nearly RMB 0.4 billion (approximately $61.4M USD) in Series B financing with involvement from international investors.

Who has invested in Scivita Medical Technology?

8 investors have backed Scivita Medical Technology across its funding rounds, including Matrix Partners China, Lilly Asia Ventures, GL Ventures LLC, Medtronic, Chengwei Capital and Inno-Chip.

Lead investors include GL Ventures LLC and Lilly Asia Ventures.


Scivita Medical Technology Investors

Investors in Scivita Medical Technology by funding rounds participated
InvestorHQRoundsRoleFirst check
Matrix Partners ChinaChinaBeijing2ParticipantApr 2021
GL Ventures LLCChinaBeijing2LeadApr 2021
Lilly Asia VenturesChinaShanghai2LeadApr 2021
Prime CapitalAustraliaSydney1ParticipantAug 2021
MedtronicUnited StatesMinneapolis, MN1ParticipantApr 2021
Chengwei CapitalChinaShanghai1ParticipantApr 2021

This data is available for Pro users. Sign up to see all 8 Scivita Medical Technology investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Scivita Medical Technology Competitors

Scivita Medical Technology competitors include listed companies like UltraGreen.ai, Wandong Medical, SonoScape and Sinocare, and private ones like Carestream and SiBionics.

Public and private companies comparable to Scivita Medical Technology
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
CarestreamChinaShanghaiPrivate--$800M-
SiBionicsChinaChinaPrivate--$717M-
UltraGreen.aiSingaporeSingaporePublicly listed$138M$78M$672M2.9x
Wandong MedicalChinaChinaPublicly listed$201M($46M)$1B3.2x
SonoScapeChinaChinaPublicly listed$344M$35M$1.2B2.8x
SinocareChinaChinaPublicly listed$695M$43M$1.3B1.8x

Scivita Medical Technology Public Comps

Scivita Medical Technology is still privately-owned, but its public comps include iRadimed, Staar Surgical, Clinica Baviera, Wandong Medical, Obsidian Therapeutics, Enovis, Shinva, PHC Holdings, Guangzhou Wondfo Biotech and Daan Gene.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
iRadimed$84M$28M11.9x11.2x36.3x32.8x
Staar Surgical$239M($37M)3.8x3.0x(24.7x)21.5x
Clinica Baviera$348M$98M2.9x2.7x10.3x9.4x
Wandong Medical$201M($46M)3.1x3.2x(13.7x)-
Obsidian Therapeutics-($104M)--(13.0x)-
Enovis$2.2B($830M)1.1x1.0x(2.9x)5.7x
Shinva$1.5B$126M0.6x0.6x6.7x6.7x
PHC Holdings$2.3B$320M1.0x1.0x7.2x6.5x

This data is available for Pro users. Sign up to see all Scivita Medical Technology competitors and their valuation data.

Start Free Trial

Common questions about Scivita Medical Technology

When was Scivita Medical Technology founded?Scivita Medical Technology was founded in 2016.
Where is Scivita Medical Technology headquartered?Scivita Medical Technology is headquartered in Suzhou, China.
Is Scivita Medical Technology publicly listed?No, Scivita Medical Technology is a private, VC-backed company.
What is Scivita Medical Technology's valuation?Scivita Medical Technology was last valued at $1.1B in its Series B in August 2021.
How much funding has Scivita Medical Technology raised?Scivita Medical Technology has raised $123M across 2 funding rounds.
What was Scivita Medical Technology's last funding round?Scivita Medical Technology's last funding round was a $62M Series B in August 2021.
Who are Scivita Medical Technology's investors?Scivita Medical Technology's investors include Matrix Partners China, GL Ventures LLC, Lilly Asia Ventures, Prime Capital, Medtronic, Chengwei Capital, Hudson Bay Capital Management and Inno-Chip.
Which companies are comparable to Scivita Medical Technology?Companies comparable to Scivita Medical Technology include Carestream, SiBionics, UltraGreen.ai, Wandong Medical, SonoScape and Sinocare.

See companies similar to Scivita Medical Technology

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial